Global Blue Biotechnology
Global Blue Biotechnology

Blue Biotechnology Comprehensive Study by Type (Enzymes, Pharma Products, Bulk Chemicals, Biopolymers), Application (Bio-Engineering, Genomics, Vaccine Development, Drug Discovery, Others), End Users (Hospitals, Research Laboratories, Pharmaceuticals Companies, Food & Beverage Companies, Biotechnology Companies) Players and Region - Global Market Outlook to 2025

Blue Biotechnology Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Sep 2020 Edition 226 Pages 200 Tables & Figures
Sample Report Speak with Analyst Request Discount
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Blue biotechnology also known as blue biotech, includes biological materials that originate from the aquatic environment, freshwater, and marine. Blue biotechnology is increasingly seen as a technical and commercially realistic direction of development and is a major sector of interest particularly in North America and the European Union. The blue biotechnology encourages the use of marine bioresources as the source of the biotechnological application. Increasing demand for organic cosmetics due to the side effects of synthetic makeup will supplement the market growth in the forecast period.

The market study is being classified by Type (Enzymes, Pharma Products, Bulk Chemicals and Biopolymers), by Application (Bio-Engineering, Genomics, Vaccine Development, Drug Discovery and Others) and major geographies with country level break-up.

Sea Run Holdings, Inc.(United States), PICES (Canada), Donald Danforth Plant Science Center (United States), Shell Marine Products (United States), Aker BioMarine (Norway), Marinova (Australia), New England Biolabs (United States), PML Applications Ltd. (United Kingdom), GeoMarine Biotechnologies (India) and GlycoMar (Scotland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Aker BioMarins (Norway), Samudra Biopharma Pvt. Ltd (India), Sanosil Biotech (India), Cellgen Biologicals Pvt Ltd. (India) and Nurture Aqua Technology Pvt. Ltd. (India).

Global blue biotechnology market consists of few established players accounting for the major market shares. To date, however, only one percent of biotech companies are engaged in blue biotechnology. The entry of private-labels in the market is expected to increase the competition levels in forecast years.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Blue Biotechnology market by Type, Application and Region.

On the basis of geography, the market of Blue Biotechnology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Issues Of Food Security And Water Availability
  • Ageing Population In Developed Economies

Market Trend
  • Microalgae Incorporation Into Innovative Food Products

Restraints
  • Lack Of Awareness About The Usage Of Marine Microorganism

Opportunities
  • Growing Demand Of Aquatic Biotechnology In Cosmetics Industry
  • Ongoing Research & Development In Blue Biotechnology

Challenges
  • Stringent Regulations For Marine And Aquatic Ecosystem


In July 2019, Archer Daniels Midland Company launched OnavitaAlgal DHA and AlmegaEPA blends via collaboration with Qualitas Health, a leader in algae cultivation. These products contains omega-3, 6 and 9
By 2020 European Union will develop and apply advanced tools, platforms and infrastructures and support to Marine Biotechnology to provide a significant contribution to addressing key societal challenges of the next decades in the areas of food and energy, development of novel drugs and treatments for human health and the sustainable use and management of the seas and oceans.

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Blue Biotechnology Providers, Venture Capitalists and Private Equity Firms, Government Regulatory, Research Organizations and End Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Enzymes
  • Pharma Products
  • Bulk Chemicals
  • Biopolymers
By Application
  • Bio-Engineering
  • Genomics
  • Vaccine Development
  • Drug Discovery
  • Others
By End Users
  • Hospitals
  • Research Laboratories
  • Pharmaceuticals Companies
  • Food & Beverage Companies
  • Biotechnology Companies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Issues Of Food Security And Water Availability
      • 3.2.2. Ageing Population In Developed Economies
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulations For Marine And Aquatic Ecosystem
    • 3.4. Market Trends
      • 3.4.1. Microalgae Incorporation Into Innovative Food Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blue Biotechnology, by Type, Application, End Users and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Blue Biotechnology (Value)
      • 5.2.1. Global Blue Biotechnology by: Type (Value)
        • 5.2.1.1. Enzymes
        • 5.2.1.2. Pharma Products
        • 5.2.1.3. Bulk Chemicals
        • 5.2.1.4. Biopolymers
      • 5.2.2. Global Blue Biotechnology by: Application (Value)
        • 5.2.2.1. Bio-Engineering
        • 5.2.2.2. Genomics
        • 5.2.2.3. Vaccine Development
        • 5.2.2.4. Drug Discovery
        • 5.2.2.5. Others
      • 5.2.3. Global Blue Biotechnology by: End Users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Research Laboratories
        • 5.2.3.3. Pharmaceuticals Companies
        • 5.2.3.4. Food & Beverage Companies
        • 5.2.3.5. Biotechnology Companies
      • 5.2.4. Global Blue Biotechnology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Blue Biotechnology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sea Run Holdings, Inc.(United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PICES (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Donald Danforth Plant Science Center (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Shell Marine Products (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aker BioMarine (Norway)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Marinova (Australia)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. New England Biolabs (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PML Applications Ltd. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GeoMarine Biotechnologies (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GlycoMar (Scotland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blue Biotechnology Sale, by Type, Application, End Users and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Blue Biotechnology (Value)
      • 7.2.1. Global Blue Biotechnology by: Type (Value)
        • 7.2.1.1. Enzymes
        • 7.2.1.2. Pharma Products
        • 7.2.1.3. Bulk Chemicals
        • 7.2.1.4. Biopolymers
      • 7.2.2. Global Blue Biotechnology by: Application (Value)
        • 7.2.2.1. Bio-Engineering
        • 7.2.2.2. Genomics
        • 7.2.2.3. Vaccine Development
        • 7.2.2.4. Drug Discovery
        • 7.2.2.5. Others
      • 7.2.3. Global Blue Biotechnology by: End Users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Research Laboratories
        • 7.2.3.3. Pharmaceuticals Companies
        • 7.2.3.4. Food & Beverage Companies
        • 7.2.3.5. Biotechnology Companies
      • 7.2.4. Global Blue Biotechnology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blue Biotechnology: by Type(USD Million)
  • Table 2. Blue Biotechnology Enzymes , by Region USD Million (2014-2019)
  • Table 3. Blue Biotechnology Pharma Products , by Region USD Million (2014-2019)
  • Table 4. Blue Biotechnology Bulk Chemicals , by Region USD Million (2014-2019)
  • Table 5. Blue Biotechnology Biopolymers , by Region USD Million (2014-2019)
  • Table 6. Blue Biotechnology: by Application(USD Million)
  • Table 7. Blue Biotechnology Bio-Engineering , by Region USD Million (2014-2019)
  • Table 8. Blue Biotechnology Genomics , by Region USD Million (2014-2019)
  • Table 9. Blue Biotechnology Vaccine Development , by Region USD Million (2014-2019)
  • Table 10. Blue Biotechnology Drug Discovery , by Region USD Million (2014-2019)
  • Table 11. Blue Biotechnology Others , by Region USD Million (2014-2019)
  • Table 12. Blue Biotechnology: by End Users(USD Million)
  • Table 13. Blue Biotechnology Hospitals , by Region USD Million (2014-2019)
  • Table 14. Blue Biotechnology Research Laboratories , by Region USD Million (2014-2019)
  • Table 15. Blue Biotechnology Pharmaceuticals Companies , by Region USD Million (2014-2019)
  • Table 16. Blue Biotechnology Food & Beverage Companies , by Region USD Million (2014-2019)
  • Table 17. Blue Biotechnology Biotechnology Companies , by Region USD Million (2014-2019)
  • Table 18. South America Blue Biotechnology, by Country USD Million (2014-2019)
  • Table 19. South America Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 20. South America Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 21. South America Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 22. Brazil Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 23. Brazil Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 24. Brazil Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 25. Argentina Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 26. Argentina Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 27. Argentina Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 28. Rest of South America Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 29. Rest of South America Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 30. Rest of South America Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 31. Asia Pacific Blue Biotechnology, by Country USD Million (2014-2019)
  • Table 32. Asia Pacific Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 33. Asia Pacific Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 34. Asia Pacific Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 35. China Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 36. China Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 37. China Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 38. Japan Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 39. Japan Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 40. Japan Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 41. India Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 42. India Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 43. India Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 44. South Korea Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 45. South Korea Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 46. South Korea Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 47. Taiwan Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 48. Taiwan Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 49. Taiwan Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 50. Australia Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 51. Australia Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 52. Australia Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 53. Rest of Asia-Pacific Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 54. Rest of Asia-Pacific Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 55. Rest of Asia-Pacific Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 56. Europe Blue Biotechnology, by Country USD Million (2014-2019)
  • Table 57. Europe Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 58. Europe Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 59. Europe Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 60. Germany Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 61. Germany Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 62. Germany Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 63. France Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 64. France Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 65. France Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 66. Italy Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 67. Italy Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 68. Italy Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 69. United Kingdom Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 70. United Kingdom Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 71. United Kingdom Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 72. Netherlands Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 73. Netherlands Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 74. Netherlands Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 75. Rest of Europe Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 76. Rest of Europe Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 77. Rest of Europe Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 78. MEA Blue Biotechnology, by Country USD Million (2014-2019)
  • Table 79. MEA Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 80. MEA Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 81. MEA Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 82. Middle East Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 83. Middle East Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 84. Middle East Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 85. Africa Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 86. Africa Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 87. Africa Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 88. North America Blue Biotechnology, by Country USD Million (2014-2019)
  • Table 89. North America Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 90. North America Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 91. North America Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 92. United States Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 93. United States Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 94. United States Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 95. Canada Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 96. Canada Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 97. Canada Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 98. Mexico Blue Biotechnology, by Type USD Million (2014-2019)
  • Table 99. Mexico Blue Biotechnology, by Application USD Million (2014-2019)
  • Table 100. Mexico Blue Biotechnology, by End Users USD Million (2014-2019)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Blue Biotechnology: by Type(USD Million)
  • Table 112. Blue Biotechnology Enzymes , by Region USD Million (2020-2025)
  • Table 113. Blue Biotechnology Pharma Products , by Region USD Million (2020-2025)
  • Table 114. Blue Biotechnology Bulk Chemicals , by Region USD Million (2020-2025)
  • Table 115. Blue Biotechnology Biopolymers , by Region USD Million (2020-2025)
  • Table 116. Blue Biotechnology: by Application(USD Million)
  • Table 117. Blue Biotechnology Bio-Engineering , by Region USD Million (2020-2025)
  • Table 118. Blue Biotechnology Genomics , by Region USD Million (2020-2025)
  • Table 119. Blue Biotechnology Vaccine Development , by Region USD Million (2020-2025)
  • Table 120. Blue Biotechnology Drug Discovery , by Region USD Million (2020-2025)
  • Table 121. Blue Biotechnology Others , by Region USD Million (2020-2025)
  • Table 122. Blue Biotechnology: by End Users(USD Million)
  • Table 123. Blue Biotechnology Hospitals , by Region USD Million (2020-2025)
  • Table 124. Blue Biotechnology Research Laboratories , by Region USD Million (2020-2025)
  • Table 125. Blue Biotechnology Pharmaceuticals Companies , by Region USD Million (2020-2025)
  • Table 126. Blue Biotechnology Food & Beverage Companies , by Region USD Million (2020-2025)
  • Table 127. Blue Biotechnology Biotechnology Companies , by Region USD Million (2020-2025)
  • Table 128. South America Blue Biotechnology, by Country USD Million (2020-2025)
  • Table 129. South America Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 130. South America Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 131. South America Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 132. Brazil Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 133. Brazil Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 134. Brazil Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 135. Argentina Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 136. Argentina Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 137. Argentina Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 138. Rest of South America Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 139. Rest of South America Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 140. Rest of South America Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 141. Asia Pacific Blue Biotechnology, by Country USD Million (2020-2025)
  • Table 142. Asia Pacific Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 143. Asia Pacific Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 144. Asia Pacific Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 145. China Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 146. China Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 147. China Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 148. Japan Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 149. Japan Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 150. Japan Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 151. India Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 152. India Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 153. India Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 154. South Korea Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 155. South Korea Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 156. South Korea Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 157. Taiwan Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 158. Taiwan Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 159. Taiwan Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 160. Australia Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 161. Australia Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 162. Australia Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 163. Rest of Asia-Pacific Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 164. Rest of Asia-Pacific Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 165. Rest of Asia-Pacific Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 166. Europe Blue Biotechnology, by Country USD Million (2020-2025)
  • Table 167. Europe Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 168. Europe Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 169. Europe Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 170. Germany Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 171. Germany Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 172. Germany Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 173. France Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 174. France Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 175. France Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 176. Italy Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 177. Italy Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 178. Italy Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 179. United Kingdom Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 180. United Kingdom Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 181. United Kingdom Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 182. Netherlands Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 183. Netherlands Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 184. Netherlands Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 185. Rest of Europe Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 186. Rest of Europe Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 187. Rest of Europe Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 188. MEA Blue Biotechnology, by Country USD Million (2020-2025)
  • Table 189. MEA Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 190. MEA Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 191. MEA Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 192. Middle East Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 193. Middle East Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 194. Middle East Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 195. Africa Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 196. Africa Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 197. Africa Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 198. North America Blue Biotechnology, by Country USD Million (2020-2025)
  • Table 199. North America Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 200. North America Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 201. North America Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 202. United States Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 203. United States Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 204. United States Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 205. Canada Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 206. Canada Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 207. Canada Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 208. Mexico Blue Biotechnology, by Type USD Million (2020-2025)
  • Table 209. Mexico Blue Biotechnology, by Application USD Million (2020-2025)
  • Table 210. Mexico Blue Biotechnology, by End Users USD Million (2020-2025)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blue Biotechnology: by Type USD Million (2014-2019)
  • Figure 5. Global Blue Biotechnology: by Application USD Million (2014-2019)
  • Figure 6. Global Blue Biotechnology: by End Users USD Million (2014-2019)
  • Figure 7. South America Blue Biotechnology Share (%), by Country
  • Figure 8. Asia Pacific Blue Biotechnology Share (%), by Country
  • Figure 9. Europe Blue Biotechnology Share (%), by Country
  • Figure 10. MEA Blue Biotechnology Share (%), by Country
  • Figure 11. North America Blue Biotechnology Share (%), by Country
  • Figure 12. Global Blue Biotechnology share by Players 2019 (%)
  • Figure 13. Global Blue Biotechnology share by Players (Top 3) 2019(%)
  • Figure 14. Global Blue Biotechnology share by Players (Top 5) 2019(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Sea Run Holdings, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 17. Sea Run Holdings, Inc.(United States) Revenue: by Geography 2019
  • Figure 18. PICES (Canada) Revenue, Net Income and Gross profit
  • Figure 19. PICES (Canada) Revenue: by Geography 2019
  • Figure 20. Donald Danforth Plant Science Center (United States) Revenue, Net Income and Gross profit
  • Figure 21. Donald Danforth Plant Science Center (United States) Revenue: by Geography 2019
  • Figure 22. Shell Marine Products (United States) Revenue, Net Income and Gross profit
  • Figure 23. Shell Marine Products (United States) Revenue: by Geography 2019
  • Figure 24. Aker BioMarine (Norway) Revenue, Net Income and Gross profit
  • Figure 25. Aker BioMarine (Norway) Revenue: by Geography 2019
  • Figure 26. Marinova (Australia) Revenue, Net Income and Gross profit
  • Figure 27. Marinova (Australia) Revenue: by Geography 2019
  • Figure 28. New England Biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 29. New England Biolabs (United States) Revenue: by Geography 2019
  • Figure 30. PML Applications Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. PML Applications Ltd. (United Kingdom) Revenue: by Geography 2019
  • Figure 32. GeoMarine Biotechnologies (India) Revenue, Net Income and Gross profit
  • Figure 33. GeoMarine Biotechnologies (India) Revenue: by Geography 2019
  • Figure 34. GlycoMar (Scotland) Revenue, Net Income and Gross profit
  • Figure 35. GlycoMar (Scotland) Revenue: by Geography 2019
  • Figure 36. Global Blue Biotechnology: by Type USD Million (2020-2025)
  • Figure 37. Global Blue Biotechnology: by Application USD Million (2020-2025)
  • Figure 38. Global Blue Biotechnology: by End Users USD Million (2020-2025)
  • Figure 39. South America Blue Biotechnology Share (%), by Country
  • Figure 40. Asia Pacific Blue Biotechnology Share (%), by Country
  • Figure 41. Europe Blue Biotechnology Share (%), by Country
  • Figure 42. MEA Blue Biotechnology Share (%), by Country
  • Figure 43. North America Blue Biotechnology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Sea Run Holdings, Inc.(United States)
  • PICES (Canada)
  • Donald Danforth Plant Science Center (United States)
  • Shell Marine Products (United States)
  • Aker BioMarine (Norway)
  • Marinova (Australia)
  • New England Biolabs (United States)
  • PML Applications Ltd. (United Kingdom)
  • GeoMarine Biotechnologies (India)
  • GlycoMar (Scotland)
Additional players considered in the study are as follows:
Aker BioMarins (Norway) , Samudra Biopharma Pvt. Ltd (India) , Sanosil Biotech (India) , Cellgen Biologicals Pvt Ltd. (India) , Nurture Aqua Technology Pvt. Ltd. (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount
Slider
Slider
Slider
DOWNLOAD SAMPLE PDF

Speak with Analyst

Want to find out more about this report?

Get Free Consultation
Ask a Question!

Related Reports

Hybrid Operating Room Comprehensive Study by Application (Cardiovascular applications, Neurosurgical applications, Thoracic applications, Orthopedic applications, Other), Technology (Fluoroscopy & Da...
Hybrid Operating Room Comprehensive Study by Application (Cardiovascular applications, Neurosurgical applications, Thoracic applications, Orthopedic applications, Other), Technology (Fluoroscopy & Da...
$ 3800
Cancer Diagnostics Comprehensive Study by Type (Platform-based, Instrument-based), Application (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institute, Other), Meth...
Cancer Diagnostics Comprehensive Study by Type (Platform-based, Instrument-based), Application (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institute, Other), Meth...
$ 3800
Vocal Biomarkers Comprehensive Study by Type (Amplitude, Error rate, Frequency, Vocal rise or fall time, Voice tremor, Pitch, Others), Indication (Psychiatric Disorders, Neurological Disorders, Respi...
Vocal Biomarkers Comprehensive Study by Type (Amplitude, Error rate, Frequency, Vocal rise or fall time, Voice tremor, Pitch, Others), Indication (Psychiatric Disorders, Neurological Disorders, Respi...
$ 3800
NewBorn Screening Comprehensive Study by Type (Instruments {Newborn Disorder Screening Instruments, Newborn Hearing Screening Instruments (Hearing Screening Devices and Hearing Screening Accessories)...
NewBorn Screening Comprehensive Study by Type (Instruments {Newborn Disorder Screening Instruments, Newborn Hearing Screening Instruments (Hearing Screening Devices and Hearing Screening Accessories)...
$ 3800
Interventional Radiology Comprehensive Study by Type (X-ray, Computed Tomography, Magnetic Resonance Imaging (MRI), Ultrasound), Application (Oncology, Cardiology, Urology & Nephrology, Gastroenterol...
Interventional Radiology Comprehensive Study by Type (X-ray, Computed Tomography, Magnetic Resonance Imaging (MRI), Ultrasound), Application (Oncology, Cardiology, Urology & Nephrology, Gastroenterol...
$ 3800
Wireless Health and Fitness Devices Comprehensive Study by Type (Wrist Strap Type Devices, Wearable Type Devices, Other), Application (Monitoring, Diagnosis), Sales Channel (Pharmacies, Online Channe...
Wireless Health and Fitness Devices Comprehensive Study by Type (Wrist Strap Type Devices, Wearable Type Devices, Other), Application (Monitoring, Diagnosis), Sales Channel (Pharmacies, Online Channe...
$ 3800